BiotechBioPharma

A biotech/biopharma small cap and trends media channel for Content Carnivores.

[BiotechBioPharma @Regencells]

Updates are good. https://t.co/Am0hMkCOxn

[BiotechBioPharma @Regencells]

$GOVX to Present at the Noble Capital Markets Emerging Growth Equity Conference December 3, 2024. Video webcast available the following day on https://t.co/BGkgb09RIJ #mpox #immunocompromised #mva

[BiotechBioPharma @Regencells]

$GOVX milestones met, including plans for a Phase 2 trial of Gedeptin for first recurrent head and neck cancer in combination with an immune checkpoint inhibitor. Full report here. https://t.co/JksNVjVHBc

[BiotechBioPharma @Regencells]

The study emphasizes the importance of considering both arms of the immune system in assessing vaccine immunogenicity, particularly in the context of immunodeficiency. #vaccines #COVID19 #immunocompromised #MVA $GOVX https://t.co/11VQPffhI2

[BiotechBioPharma @Regencells]

This conference is for innovators. See presentation time and company info. #biotech #demycolton #healthcare #BioFuture2023
https://t.co/QdlRPQ45Ts

[BiotechBioPharma @Regencells]

This conference is for innovators. See presentation time and company info. #biotech #demycolton #healthcare #BioFuture2023
https://t.co/QdlRPQ45Ts

[BiotechBioPharma @Regencells]

Innovators & Investors Come Together to Shape the Future of Healthcare. #biotech, #demy-colton, #innovators, #disruptors #BioFuture2023 Learn more and register here. https://t.co/1KLtU6gbmw

[BiotechBioPharma @Regencells]

GeoVax Announces Gedeptin® Presentation at the AACR-AHNS Head and Neck Cancer Conference. Another milestone for late-stage cancer patients with ongoing clinical trials. https://t.co/glVlLYyNCA

[BiotechBioPharma @Regencells]

Biopharma trends leaders should consider for 2023 https://t.co/mGMbEqm0uM

[BiotechBioPharma @Regencells]

Moderna cancer vaccine reduces melanoma's return by 44% https://t.co/ji9WiNSLNM

[BiotechBioPharma @Regencells]

Be here during biotech's biggest week of the year. https://t.co/VLC9qO8LCq #BiotechShowcase2023 #BiotechShowcase #digimed #medtech #biotech #pharma @demycolton @AIVITABio @Mediphage @OpusGenetics @Allergenis @Enveric_Bio $ENVB

[BiotechBioPharma @Regencells]

All major biotech categories. https://t.co/VLC9qO8LCq #BiotechShowcase2023 #digimed #medtech #biotech #pharma @demycolton

[BiotechBioPharma @Regencells]

Entact Bio makes its Series A debut with $81M to launch protein enhancement platform https://t.co/yomo9pX2sC

[BiotechBioPharma @Regencells]

Here's why we're not prepared for the next wave of biotech innovation https://t.co/k7HHyNGZCj

[BiotechBioPharma @Regencells]

A biotech startup using a high throughput platform to screen chemical compounds and natural substances for developing drugs and treatments for aging related diseases. https://t.co/1KLtU6gbmw #Biofuture2022 #biotechnology #nuclearphysics #therapy @demycolton

[BiotechBioPharma @Regencells]

Developing a novel class of sensitisers to immune checkpoint blockade therapy. https://t.co/1KLtU6gbmw #Biofuture2022 #pharmaceutical #immune #therapy @demycolton

[BiotechBioPharma @Regencells]

FDA approves J&J's BCMA-targeted bispecific for multiple myeloma https://t.co/9SnBct7jz2

[BiotechBioPharma @Regencells]

Large insurer's decision to cover some prescription digital therapies may be a milestone for app makers https://t.co/k1GME7t0V5

[BiotechBioPharma @Regencells]

Pacific Biosciences, known for niche DNA sequencing, looks to rival Illumina with new product launch https://t.co/opKajf0W5V

[BiotechBioPharma @Regencells]

Automatically building large databases of images and data on live cells and tissues for data mining, machine learning and breakthrough insights. https://t.co/1KLtU6gbmw #Biofuture2022 #biotechnology #data #cells #cellimaging #breakthrough #machinelearning @demycolton